Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil
Rev. Soc. Bras. Med. Trop; 50 (1), 2017
ABSTRACT INTRODUCTION Despite their high toxicity, antimonials and amphotericin B deoxycholate are commonly used for treating visceral leishmaniasis (VL). Few studies showing conflictive data about their efficacy and adverse events in pediatric population are available. This study aimed to evaluate eff...
Anfotericina B/efectos adversos, Anfotericina B/uso terapéutico, Antiprotozoarios/efectos adversos, Antiprotozoarios/uso terapéutico, Ácido Desoxicólico/efectos adversos, Ácido Desoxicólico/uso terapéutico, Combinación de Medicamentos, Leishmaniasis Visceral/tratamiento farmacológico, Meglumina/efectos adversos, Meglumina/uso terapéutico, Antimoniato de Meglumina, Compuestos Organometálicos/efectos adversos, Compuestos Organometálicos/uso terapéutico, Proyectos Piloto, Resultado del Tratamiento